EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents
Maiken Cavling Arendrup(Copenhagen University Hospital), Paul E. Verweij(Radboud University Nijmegen), Mihai Mareș(King Saud University), Sevtap Arıkan-Akdağlı(Hacettepe University), Cornelia Lass‐Flörl(Innsbruck Medical University), Francesco Barchiesi(Marche Polytechnic University), Cecilie Torp Andersen(Oslo University Hospital), Konrad Muehlethaler(Instituto de Salud Carlos III), Thomas R. Rogers(Scripps Research Institute), Petr Hamal(Palacký University Olomouc), Tadeja Matos, M. Cuenca-Estrella(Instituto de Salud Carlos III), H. Järv(Instituto de Salud Carlos III)
Cited by 134
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
|Clinical Microbiology and Infection|2011|752